Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Exar Corporation (“Exar”) (NYSE: EXAR) concerning the sale to MaxLinear, Inc. Under the terms of the agreement, Exar shareholders will only receive $13.00 for each share owned. If you are an affected investor, and you…